Results 71 to 80 of about 149 (88)

A Mini-Review of the NADPH Oxidases in Vascular Dementia: Correlation with NOXs and Risk Factors for VaD

International Journal of Molecular Sciences, 2017
Dong-Hee Choi, Jongmin Lee, Choi Dong-Hee   +2 more
exaly  

VAD Regimen in the Treatment of Resistant Multiple Myeloma: Slow or Fast Infusion?

Leukemia and Lymphoma, 1993
Tarja-Terttu Pelliniemi, Kari Remes
exaly  

Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)

Cancer, 2006
Montserrat Rue, Richard A Larson, Pieter Sonneveld   +2 more
exaly  

Postoperative Management of the VAD Patient

2022
Sarah Schettle
exaly  

VAD-Cyclosporine Therapy for VAD-Resistant Multiple Myeloma

Leukemia and Lymphoma, 1995
D Weber, Meletios A Dimopoulos, Frank A Sinicrope   +2 more
exaly  

Microlens formation on VAD single-mode fibre ends

Electronics Letters, 1982
M Kawachi, T Edahiro, H Toba
exaly  

Maintenance therapy with alpha‐interferon following first‐line VAD in multiple myeloma

European Journal of Haematology, 1997
A Kars, Ismail Çelik, Emin Kansu
exaly  

Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cell apoptosis and follicular death after human ovarian tissue transplantation

Journal of Assisted Reproduction and Genetics, 2018
Maite Fransolet, Laurie Henry, Soraya Labied   +2 more
exaly  

Reduced risk of bacterial infection in multiple myeloma patients with VAD regimen without intermittent high-dose dexamethasone

International Journal of Hematology, 2010
Hirotaka Nakahashi, Morio Sawamura, Isoda Atsushi   +2 more
exaly  

Data quality control method for VAD wind field retrieval based on coherent wind lidar

Hongwai Yu Jiguang Gongcheng/Infrared and Laser Engineering, 2018
exaly